Paper Details

  1. Home
  2. Paper Details

Smartphone Cognitive Behavioral Therapy as an Adjunct to Pharmacotherapy for Refractory Depression: Randomized Controlled Trial.

Author: ChinoBun, FunayamaTadashi, FurukawaToshi A, HiroeTakahiro, HorikoshiMasaru, ImaiHissei, KatoTadashi, KawanishiNao, MantaniAkio, YonemotoNaohiro, ZhouQi

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

A smartphone cognitive behavioral therapy (CBT) app was more effective than medication switch alone in reducing depression severity and improving other symptoms in patients with antidepressant-resistant major depression. The patients allocated to the CBT app scored 2.48 points lower on the PHQ-9 than the control group at week 9. The treatment benefits were maintained up to week 17.
Paper Details　
Original Abstract of the Article :
BACKGROUND: In the treatment of major depression, antidepressants are effective but not curative. Cognitive behavioral therapy (CBT) is also effective, alone or in combination with pharmacotherapy, but accessibility is a problem. OBJECTIVE: The aim is to evaluate the effectiveness of a smartphone C...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695656/

データ提供：米国国立医学図書館（NLM）

Smartphone Cognitive Behavioral Therapy for Refractory Depression: A New Frontier in Mental Health

Major depression, a prevalent mental health condition, can be challenging to treat. This study evaluates the effectiveness of a smartphone-based cognitive behavioral therapy (CBT) app as an adjunct to pharmacotherapy for patients with antidepressant-resistant depression. Researchers conducted a randomized controlled trial, comparing the combined approach of medication switch plus smartphone CBT to medication switch alone. They found that the smartphone CBT app significantly improved depression severity and other symptoms, indicating its potential as a valuable tool for managing refractory depression.

Bridging the Gap: Smartphone CBT for Depression Management

This study demonstrates the potential of smartphone CBT to bridge the gap in access to mental health care. The results suggest that this novel approach can be a valuable addition to traditional treatments, potentially improving outcomes for patients with refractory depression. It's like building a bridge across a desert canyon, connecting those in need with the resources they require.

A New Era of Mental Health: Smartphone CBT for Refractory Depression

This research opens exciting possibilities for the future of mental health treatment. The findings highlight the potential of smartphone-based interventions to address the challenges of access, affordability, and accessibility. It's like discovering a new oasis in the desert of mental health, providing a much-needed source of relief and support.

Dr. Camel's Conclusion

This study presents compelling evidence for the effectiveness of a smartphone CBT app in managing antidepressant-resistant depression. This research suggests that smartphone-based interventions can be a valuable tool for improving access to mental health care and expanding treatment options for those struggling with refractory depression.

Date :
  1. Date Completed 2018-03-19
  2. Date Revised 2018-12-08
Further Info :

Pubmed ID

29101095

DOI: Digital Object Identifier

PMC5695656

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.